Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
astrazeneca
3
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
3
×
pfizer
3
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
bristol-myers squibb
eli lilly
finch therapeutics
merck
microbiome
president trump
10x genomics
adalimumab
What
bio
drug
roundup
seven
acquisitions
august
away
biggest
biotech
bringing
build
busy
buy
ceo
ceos
company’s
daniel
days
dc
debut
decisions
devices
drugs
dyne’s
executives
fda
gathered
gilead
groups
hearing
held
legacy
lower
microbiome
moves
news
nods
openly
opioid
o’day
Language
unset
Current search:
astrazeneca
×
novartis
×
pfizer
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away